Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,779 | -59,504 | -14,943 | -32,571 | N/A |
| Depreciation Amortization | 8,676 | 5,128 | 5,925 | 6,507 | N/A |
| Accounts receivable | -1,952 | 4,041 | -8,711 | 14,147 | N/A |
| Accounts payable and accrued liabilities | 1,970 | 3,485 | -2,041 | 770 | N/A |
| Other Working Capital | 30,956 | 58,102 | 31,794 | 16,265 | N/A |
| Other Operating Activity | 27,558 | 11,162 | 13,894 | -10,723 | 0 |
| Operating Cash Flow | $-18,571 | $22,414 | $25,918 | $-5,605 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -99,181 | N/A | N/A | N/A |
| PPE Investments | -1,975 | -8,108 | -6,804 | -742 | N/A |
| Purchase Of Investment | -41,736 | N/A | 0 | -2,160 | N/A |
| Sale Of Investment | 37,843 | N/A | 17,582 | 22,054 | N/A |
| Investing Cash Flow | $-5,868 | $-107,289 | $10,778 | $19,152 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 11,500 | 17,300 | N/A |
| Debt Issued | N/A | N/A | 1,153 | N/A | N/A |
| Debt Repayment | -403 | -403 | -732 | -714 | N/A |
| Common Stock Issued | 14,992 | 177,630 | 84 | 150 | N/A |
| Other Financing Activity | -2,243 | -3,135 | -11,325 | -9,929 | 0 |
| Financing Cash Flow | $12,346 | $174,092 | $680 | $6,807 | $N/A |
| Exchange Rate Effect | -38 | -94 | 84 | -66 | N/A |
| Beginning Cash Position | 165,455 | 76,332 | 38,872 | 18,584 | N/A |
| End Cash Position | 153,324 | 165,455 | 76,332 | 38,872 | N/A |
| Net Cash Flow | $-12,131 | $89,123 | $37,460 | $20,288 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,571 | 22,414 | 25,918 | -5,605 | N/A |
| Capital Expenditure | -1,977 | -8,118 | -6,806 | -744 | N/A |
| Free Cash Flow | -20,548 | 14,296 | 19,112 | -6,349 | 0 |